NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Chelsea and Westminster NHS Foundation Trust
Conditions: HIV Infections, Gender Identity, Human Immunodeficiency Virus
Countries: Italy, United Kingdom
The project will study a European cohort of individuals identifying themselves as transgender or non-binary and living with HIV. The study will collect both qualitative data on this cohort and clinical data over an 18 month period. The study will investigate the success of HIV treatment for this cohort through the primary outcome measure of HIV viral load recorded in routine blood tests. The results from this study will assist in informing future HIV treatment guidelines on the monitoring of HIV infection in transgender and non-binary individuals and assisting in the design of future interventional studies within this population.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Participant self-identifies as transgender and/or has a current gender identity which differs from gender assigned at birth (includes all gender diverse people) * Age \> 18 years * HIV infection diagnosis at any time before study consent * Having been prescribed antiretroviral therapy at any time (including people for who antiretroviral therapy initiation is planned after study enrolment) * Willing to sign an informed consent and take part in the study Exclusion Criteria: * Age \< 18 years * Unable to take part in the study according to the Investigator opinion (example: unable to understand the study information leaflet, unable to provide written consent, etc.)
- Torino, Italy
- London, Greater London, United Kingdom
- Manchester, Greater Manchester, United Kingdom
- Brighton, Sussex, United Kingdom